EMJ GOLD: Pharma news, views and analysis

This National Blood Week, the team sit down with Anita Gandhi, Vice President, Translational Development, BMS, to explore the last decade of innovation in hematology and what lies ahead for the space. Together, Anita and Jade discuss Anita's route into the pharmaceutical industry, the current unmet needs of patients with blood cancer, what the future of innovation looks like in hematology and what...

This week on the podcast, the team are joined by omnichannel engagement expert Yacin Marzouki, who shares his strategies on how to make omnichannel work for both pharmaceutical companies and healthcare professionals.   Together, Yacin and Jade sit down in the studio to explore what it takes to harmonise omnichannel across an organisation, why content activation is still a major hurdle, how to make...

The EMJ GOLD podcast is back for a new season! In the first episode of season 10, the team are joined by Dheepa Chari, Vice President and Head of Global Scientific Communications, GSK, to discuss the past, present and future of scientific communications. Together, Dheepa and Isabel explore her journey from biostatistics to biopharma leadership — and the lessons learned along the way. They discuss...

Season 10 is on the horizon, but before we release our first episode, why not tune in to some of Isabel and Jade's favourite moments from season 9?   From leadership insights from top CEOs to navigating setbacks in R&D, there's plenty to discover in this season's batch of GOLD Medal Moments.    As well as the EMJ GOLD team, you'll hear from four former guests:   Charl van Zyl , CEO, Lundbeck Pharm...

Join Isabel and Jade as they wrap up Season 9 of the podcast with special guest Dennise Broderick, President and Managing Director, Galen Pharma.   In this episode, Jade and Dennise discuss her move from academia to the pharmaceutical industry, her lifelong ambition to be a leader and how she approaches hard decisions in business.   A little more on EMJ GOLD's guest… Dennise is Managing Director a...

How can pharmaceutical companies best navigate setbacks in drug development to deliver breakthroughs in R&D? Find out in this week's episode, where Isabel and Jade share an interview with Christoph von der Goltz, Global Head of Medicine Central Nervous System and Emerging Areas, Boehringer Ingelheim.   Together, he and Jade explore the ins and outs of drug failure, whether to pivot or persevere af...

Join Isabel and Jade this week as they delve into lessons in leadership and patient centricity with Rebecca Vermeulen, recipient of the Healthcare Businesswomen's Association (HBA) STAR award for 2025.   Rebecca shares her journey from pharmacist to industry leader, discussing her approach to leadership, the current landscape for women in pharma and what effective patient centricity looks like in...

Join Isabel and Jade as they uncover how AI is shaking up the radiology space and beyond with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth.   Together, Naiara and Jade explore what first drew the marketing leader to the healthcare sector, why radiology in particular has seen such a boost from artificial intelligence, what other therapy areas can learn from space and much m...

This week, join Isabel and Jade as they explore what's on the horizon for cardiac care, focusing on the revolutionary impact of remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific.   He and Isabel discuss Angelo's recent career change into the industry, how technology could reform the UK's NHS, the role of remote monitoring in patient wellbeing and...

Join Isabel and Jade as they explore the persistent misunderstandings of women's health in modern medicine with Mary Stutts, CEO of the Healthcare Businesswomen's Association.   In this episode, Mary unpacks the key findings of the HBA's latest report, which exposes critical gaps in doctors' understanding of women's health. She discusses the root causes, the real-world consequences and what the ph...

Why do we forget? Join Isabel and Jade as they explore the science behind memory, recall and retention, and uncover why interactive content could be the key to making information stick. In this episode, discover how interactivity enhances learning, helps HCPs recognise the value of new therapies and ultimately improves patient care. Read our article exploring the topic further  here .  And if you'...

Join Isabel and Jade for part two of their World Cancer Day special for 2025, where guest Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson, uncovers more of his insights into the oncology space.   In this instalment, Martin shares his thoughts on improving access to innovative cancer medicines, improving public trust toward the industry and h...

Join Isabel and Jade as they present a special World Cancer Day 2025 edition of the podcast. They are joined by Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA,  Johnson & Johnson .   In this first instalment of the conversation, Martin and Jade discuss this year's theme 'United by Unique', the increasing importance of real-world evidence in oncology and impro...

The EMJ GOLD podcast is back for a new season! In the first episode of Season 9, the team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders, making this the 'decade of the brain', and how industry can do more to support patients living brain conditions.   Together, Charl and Isabel explore his career journey in...

Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year's predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead.   The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ's own Dr Jonathan Sacki...

As 2024 comes to a close, it's time to look back on a year in the pharmaceutical industry. In this final episode of the year, Isabel and Jade are joined by three former guest to reflect on the pivotal moments that defined the past 12 months. They are joined by Jennifer Schranz from Ipsen, Martina Dempsey from Astellas and Elias Revonta, CEO of Orcason, who all return to the podcast to share their...

In this final episode of the season, Isabel discusses how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Head, Global Medical Affairs, Women's Health, Bayer. Menopause affects over 50% of the world's population, but its symptoms and effects are often misunderstood or ignored. Find out how industry can help by equipping not only HCPs but...

Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the last couple of months? From an insight into why Gen Z might be turning their sails towards the pharmaceutical industry, to a call for a better understanding of HIV stigma, there's plenty to discover in this season's GOLD Medal Moments.

In this episode of the EMJ GOLD podcast, Jade and Isabel explore one of the most urgent global health issues: antimicrobial resistance (AMR). As part of World AMR Awareness Week, they are highlighting this year's theme 'Educate. Advocate. Act now'. Joining the conversation is Elias Revonta, Founder and CEO, Orcason Medical, who shares his vision for tackling AMR through groundbreaking medical tech...

In this episode, Isabel welcomes Patrick Oliver, General Manager for the UK and Ireland at Alfasigma, to explore the company's exciting entry into the UK market and the evolving landscape of healthcare in the country.    In the conversation, Patrick brings his wealth of industry experience to share his vision for Alfasigma's future, the potential he sees in the UK healthcare market and the unique...

As 2024 draws to a close, what should pharma teams be focusing their budgets on for the final quarter of the year? Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024. As teams finalise their budgets and plan for the final quarter and year ahead, this conversation brings insights into how strategies like personalised engagement, thought leadership and int...

In this new episode, the team welcomes Jennifer Schranz, Senior Vice President, Global Head of Rare Diseases, Ipsen, to investigate the burden faced by women with rare diseases. Together, Jennifer and Jade discuss how the industry can address challenging rare diseases and making a meaningful impact on patients' lives, the double jeopardy that women with rare diseases face, recent breakthroughs in...

In the latest episode of our podcast, we welcome Richard Lowenthal, CEO, ARS Pharmaceuticals, to explore the company's mission to address unmet needs in allergy care. During the conversation, Richard shares insights into his early career at the FDA and the regulatory challenges he faced in bringing ARS's new nasal spray to treat severe allergic reactions to market. He also discusses the future dir...

In the latest episode, Jade sits down with Martina Dempsey, Vice President of Commercial Strategy and Operations at Astellas Europe, to discuss empowering women in the pharmaceutical industry.   They explore how pharma meets the needs and values of young graduates, the ongoing challenges women face in securing leadership roles, the critical impact of mentorship on career development and much more....

In this episode, Isabel is joined by Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim, to mark World Mental Health Day on 10 October 2024.   Their conversation dives into the unique challenges faced by those living with serious mental illnesses, the impact of media representation and the role pharma can play in transforming treatment and q...